A Study of Different Injectable Formulations of LY3375880 in Healthy Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 1, 2019

Primary Completion Date

September 19, 2019

Study Completion Date

September 19, 2019

Conditions

Healthy

Interventions

DRUG

LY3375880

Administered SC

DRUG

Buffer Matrix (No LY3375880)

Administered SC

DEVICE

Autoinjector (AI)

AI used to administer LY3375880 or Buffer Matrix

DEVICE

Manual Syringe

Manual syringe used to inject LY3375880

Trial Locations (2)

Covance Clinical Research Inc, Daytona Beach

Covance, Dallas

All Listed Sponsors

lead

Eli Lilly and Company

INDUSTRY

NCT03913260 - A Study of Different Injectable Formulations of LY3375880 in Healthy Participants | Biotech Hunter | Biotech Hunter